Oh but it gets better @Phaedrus … he then goes onto to claim Mesoblast is only worth circa $30 million because of what stage of development we are at …. Gilead paid $11.9 billion for Kite Pharma with an FDA approval pending back in 2017 and a late stage pipeline but hey $11.9 billion and $30 million seem comparable / similar don’t they …. LMAO
$30 million - I am glad he posted such absurdities so people can see just how detached from reality he really is and/or just how far he will go to down ramp
https://www.gilead.com/news-and-pre...iences-to-acquire-kite-pharma-for-119-billion
August 28, 2017
Gilead Sciences to Acquire Kite Pharma for $11.9 Billion
-- Kite's Lead CAR T Therapy Candidate, Axicabtagene Ciloleucel, Under Priority Review in the U.S. and Expedited Review in the EU
-- Provides Broad Pipeline in Hematologic Malignances and Solid Tumors and Robust Platform for Continued Innovation
-- Leverages Gilead's Expertise in Rapidly Advancing Therapies to Address Unmet Patient Needs --
2023 The Final Countdown, page-2117
-
- There are more pages in this discussion • 1,287 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |